Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 2Phase 3 Interventional

Pivotal 1 Study of ABBV-RGX-314 (Also Known as RGX-314) Gene Therapy Administered Via Subretinal Delivery One Time in Participants With nAMD

ClinicalTrials.gov ID: NCT04704921

Public ClinicalTrials.gov record NCT04704921. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 9:56 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Partially Masked, Controlled, Phase 2b/3 Clinical Study to Evaluate the Efficacy and Safety of RGX-314 Gene Therapy in Participants With nAMD (ATMOSPHERE)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

ABBV-RGX-314 (also known as RGX-314) is being developed as a novel one-time gene therapy for the treatment of neovascular (wet) age-related macular degeneration (wet AMD or nAMD). Wet AMD is characterized by loss of vision due to new, leaky blood vessel formation in the retina. Wet AMD is a significant cause of vision loss in the United States, Europe and Japan, with up to 2 million people living with wet AMD in these geographies alone. Current anti-vascular endothelial growth factor (anti-VEGF) therapies have significantly changed the landscape for treatment of wet AMD, becoming the standard of care due to their ability to maintain or prevent progression of vision loss in the majority of patients. These therapies, however, require life-long intraocular injections, typically repeated every 4 to 16 weeks in frequency, to maintain efficacy. Due to the burden of these treatments, patients often experience a decline in vision with reduced frequency of treatment over time.

Study identification

NCT ID
NCT04704921
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 2, Phase 3
Lead sponsor
AbbVie
Industry
Enrollment
671 participants

Conditions and interventions

Eligibility (public fields only)

Age range
50 Years to 89 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 29, 2020 (Actual)
Primary completion
Dec 2026 (Estimated)
Completion
Nov 2027 (Estimated)
Last update posted
Apr 28, 2026

2020 – 2027

United States locations

U.S. sites
89
U.S. states
34
U.S. cities
80
Facility City State ZIP Site status
Retinal Research Institute /ID# 256019 Phoenix Arizona 85053 —
Barnet Dulaney Perkins Eye Center - Sun City /ID# 256055 Sun City Arizona 85351 —
University of Arkansas for Medical Sciences /ID# 271290 Little Rock Arkansas 72205 —
Retina Vitreous Assoc Med Grp /ID# 256299 Beverly Hills California 90211 —
Retinal Diagnostic Center /ID# 256137 Campbell California 95008 —
The Retina Partners - Encino /ID# 256054 Encino California 91436 —
Retina Consultants of Orange County /ID# 256152 Fullerton California 92835 —
Salehi Retina Institute /ID# 263485 Huntington Beach California 92647 —
UC Irvine/Gavin Herbert Eye Institute /ID# 256145 Irvine California 92697 —
Northern California Retina Vitreous Associates Medical Group, Inc /ID# 256298 Mountain View California 94040-4101 —
UCLA Doheny Eye Center /ID# 256120 Pasadena California 91105 —
California Eye Specialists Medical Group Inc. /ID# 256079 Pasadena California 91107 —
Retina Consultants of San Diego /ID# 256021 Poway California 92064-2530 —
Retinal Consultants Medical Group /ID# 256047 Sacramento California 95825 —
West Coast Retina /ID# 256448 San Francisco California 94107 —
University of California, San Francisco /ID# 256130 San Francisco California 94143 —
Orange County Retina Medical Group /ID# 256073 Santa Ana California 92705 —
California Retina Consultants - Santa Barbara /ID# 256017 Santa Barbara California 93103 —
Retina Consultants of Southern Colorado /ID# 256069 Colorado Springs Colorado 80909 —
Southwest Retina Research Center /ID# 256136 Durango Colorado 81303 —
Colorado Retina Associates /ID# 256121 Lakewood Colorado 80228 —
Retina Group of New England - Waterford /ID# 256071 Waterford Connecticut 06385-1215 —
Advanced Research, LLC /ID# 275451 Deerfield Beach Florida 33064-1342 —
Vitreoretinal Associates, P.A. /ID# 256150 Gainesville Florida 32607 —
Florida Retina Consultants /ID# 265661 Lakeland Florida 33805 —
Bascom Palmer Eye Institute - University of Miami /ID# 256072 Miami Florida 33136 —
Retina Specialty Institute /ID# 256153 Pensacola Florida 32503 —
Retina Vitreous Associates of Florida - St. Petersburg /ID# 256050 St. Petersburg Florida 33711-1141 —
Southern Vitreoretinal Associates /ID# 256158 Tallahassee Florida 32308 —
Southeast Retina Center /ID# 256022 Augusta Georgia 30909 —
Georgia Retina - Marietta /ID# 256142 Marietta Georgia 30060 —
Marietta Eye Clinic /ID# 268163 Marietta Georgia 30060 —
Thomas Eye Group PC /ID# 268159 Sandy Springs Georgia 30328-4411 —
Retina Consultants of Hawaii /ID# 256049 ‘Aiea Hawaii 96701 —
University of Illinois at Chicago /ID# 256300 Chicago Illinois 60607 —
University Retina and Macula Associates /ID# 256078 Lemont Illinois 60439 —
University Retina and Macula Associates /ID# 256077 Oak Forest Illinois 60452 —
Springfield Clinic /ID# 266225 Springfield Illinois 62702-3749 —
Retina Partners Midwest, PC /ID# 256045 Indianapolis Indiana 46290 —
John-Kenyon American Eye Institute -New Albany /ID# 256065 New Albany Indiana 47150-3620 —
Retina Associates - Lenexa /ID# 256080 Lenexa Kansas 66215 —
Cincinnati Eye Institute- Edgewood /ID# 256132 Edgewood Kentucky 41017-3415 —
Retina Associates of New Orleans /ID# 272440 Metairie Louisiana 70006-2940 —
Ochsner Medical Center - Jefferson Highway /ID# 270524 New Orleans Louisiana 70121 —
The Retina Care Center /ID# 256144 Baltimore Maryland 21209 —
Johns Hopkins Hospital /ID# 256015 Baltimore Maryland 21287 —
The Retina Group Of Washington - Chevy Chase /ID# 276039 Chevy Chase Maryland 20815 —
Cumberland Valley Retina Consultants - Hagerstown /ID# 256151 Hagerstown Maryland 21740 —
Ophthalmic Consultants of Boston /ID# 256014 Boston Massachusetts 02114 —
Retina Associates of Michigan /ID# 266198 Grand Blanc Michigan 48439 —
Associated Retinal Consultants /ID# 256156 Royal Oak Michigan 48073 —
VitreoRetinal Surgery PLLC DBA Retina Consultants of Minnesota /ID# 256160 Edina Minnesota 55435 —
Mayo Clinic - Minnesota /ID# 256051 Rochester Minnesota 55905 —
The Retina Institute /ID# 266587 St Louis Missouri 46214 —
Sierra Eye Associates /ID# 256020 Reno Nevada 89502 —
Eye Associates of New Mexico /ID# 256075 Albuquerque New Mexico 87109 —
Long Island Vitreoretinal Consultants /ID# 256074 Great Neck New York 11021 —
Retina-Vitreous Surgeons of Central New York - Liverpool /ID# 266274 Liverpool New York 13088 —
Duke Eye Center /ID# 256076 Durham North Carolina 27705 —
Atrium Health Wake Forest Baptist Medical Center /ID# 270767 Winston-Salem North Carolina 27157 —
Retina Associates of Cleveland-Middleburg Heights /ID# 256052 Cleveland Ohio 44130 —
Cleveland Clinic Main Campus /ID# 256064 Cleveland Ohio 44195 —
Retina Vitreous Center, Research /ID# 256067 Edmond Oklahoma 73013 —
Verum Research, LLC /ID# 266585 Eugene Oregon 97401 —
Retina Northwest, PC /ID# 256140 Portland Oregon 97221 —
Erie Retina Research /ID# 256154 Erie Pennsylvania 16507 —
Retina Vitreous Consultants - Monroeville /ID# 271654 Monroeville Pennsylvania 15146 —
Mid Atlantic Retina /ID# 256013 Philadelphia Pennsylvania 19107 —
Charleston Neuroscience Institute /ID# 256235 Ladson South Carolina 29456 —
Black Hills Regional Eye Institute /ID# 256161 Rapid City South Dakota 57701 —
Charles Retina Institute /ID# 256016 Germantown Tennessee 38138 —
Retina Research Institute of Texas /ID# 256141 Abilene Texas 79606-1224 —
Austin Research Center for Retina /ID# 256148 Austin Texas 78705 —
Austin Retina Associates - Austin /ID# 256053 Austin Texas 78705 —
Austin Clinical Research, LLC /ID# 256043 Austin Texas 78750-2298 —
Retina Consultants of Texas - Beaumont /ID# 266279 Beaumont Texas 77707 —
Retina and Vitreous of Texas /ID# 263961 Bellaire Texas 77401 —
Texas Retina Associates - Dallas /ID# 256133 Dallas Texas 75231 —
Baylor Scott & White Surgicare /ID# 256122 Fort Worth Texas 76104 —
Retina Consultants Of Texas /ID# 268611 San Antonio Texas 78240 —
Stone Oak Surgery Center /ID# 266199 San Antonio Texas 78240 —
Retina Center Of Texas (Rct) - Southlake /ID# 256056 Southlake Texas 76092 —
Retina Consultants - The Woodlands /ID# 256018 The Woodlands Texas 77384 —
Retina Associates of Utah /ID# 256044 Salt Lake City Utah 84107 —
John A. Moran Eye Center /ID# 256068 Salt Lake City Utah 84132 —
Wagner Macula & Retina Center - Norfolk /ID# 256134 Norfolk Virginia 23502 —
Pacific Northwest Retina /ID# 256155 Bellevue Washington 98004 —
Retina Center NW, PLLC /ID# 256157 Silverdale Washington 98383 —
University of Wisconsin-Madison, Department of Ophthalmology and Visual Sciences /ID# 256159 Madison Wisconsin 53705-3644 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04704921, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 28, 2026 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04704921 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →